USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Asensus Surgical Europe S.a.r.l.

USPTO PatentsView assignee record - 16 granted patents across 10 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Asensus ranks #17,459 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 10 technology areas.

#17,459
of 49,997 US assignees by volume
Top 15%
by Innovation Score (49.2/100)
13.7
avg claims per patent

USPTO PatentsView assignee plate

Corpus R17459 · Foreign Corporation #17,459 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 16 grants
  • MID-PACK #17,459/49,997
  • PHOTO-FINISH AquaBeam
  • CPC-FOCUS A61B · 10 areas
  • INNOV-PAR 49.2/100
  • CLAIMS-RICH 13.7 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2021–2025 · 5y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: AquaBeam, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Asensus’s 49.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Asensus

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Asensus's Innovation Score is 49.2/100 (top 15% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Asensus?

Each dot is one of Asensus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Asensus’s own 13.7 claims/patent is at or below the 15.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Asensus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 15.915.91616.1 121416182022 Granted patents (volume) Avg claims / patent AquaBeam, LLC - 16, 19.44AquabeamArdea Biosciences, Inc - 16, 12.75Ardea BiosciencesArriver Software AB - 16, 15.62Arriver Software…Arrowhead Research Corporation - 16, 13.44Arrowhead ResearchAspenTech Corporation - 16, 20.69AspentechAstro Technology Group, LLC - 16, 18.69Astro Technology…Atritech, Inc. - 16, 12.62AtritechAttivo Networks Inc. - 16, 15.44Attivo NetworksAsensus Surgical Europe S.a.r.l. - 16, 13.69Asensus Surgical…
Asensus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Asensus's grants concentrate

Asensus Surgical Europe S.a.r.l. is a focused PatentsView assignee: 10 CPC subclasses with 93.8% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (5 grants) versus a trough of 2 in 2021. By volume, Asensus sits between AquaBeam, LLC and Attivo Networks Inc..

Asensus's three-year grant acceleration

Asensus Surgical Europe S.a.r.l. shows 8 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Asensus's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Asensus holds 16 patents at rank #17,463, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Asensus

By rank, the assignees closest to #17,463 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Asensus's primary technology class.

Asensus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 15% higher than 85% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

1234567 2021202320242025 6
USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
Asensus Surgical Europe S.a.r.l. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 2 12.5%
2023 3 18.8%
2024 5 31.3%
2025partial year 6 37.5%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Asensus Surgical Europe S.a.r.l.'s patent record in context - here's where to go next.

  • Asensus Surgical Europe S.a.r.l.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 93.8% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #17,459 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Asensus Surgical Europe S.a.r.l. against AquaBeam, LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 49.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.